Agilent Supports India's Global Biopharma Ambitions with State-of-the-Art Experience Center in Hyderabad
The new Agilent Biopharma Experience Center in Hyderabad presents a major opportunity to accelerate the city's leadership in life sciences and healthcare innovation. Designed to support the full drug development journey, the center brings together advanced lab technologies, expert training, and regulatory-ready workflows to help researchers, scientists, and companies develop high-quality, life-saving medicines faster and more efficiently. It offers end-to-end solutions across key modalities such as chromatography, mass spectrometry, cell analysis, and lab informatics, allowing companies to simulate real lab environments, test for quality and compliance, and co-create market-ready solutions tailored to both Indian and global needs.
For Hyderabad's vibrant ecosystem of startups, academic institutions, and skilled professionals, the center unlocks direct access to global expertise, cutting-edge instrumentation, and real-world application environments. It supports faster R&D, hands-on training aligned with international regulatory standards, and stronger collaboration between industry and academia. By addressing critical challenges in biosimilars, biologics, and precision medicine, the facility strengthens Hyderabad's position as a trusted global hub for next-generation drug development, and a key contributor to India's biopharma growth story.
'India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation,' said Padraig McDonnell, CEO, Agilent Technologies.
'Our future will be defined by continued innovation and a relentless focus on our customers. This new center reflects our commitment to delivering integrated solutions that help bring life-changing therapies to market faster and more efficiently. It also reinforces our support for the 'Make-in-India' initiative by empowering local innovation, nurturing talent, and enabling scalable, affordable, and sustainable solutions.'
Located in the heart of India's life sciences capital, the center is designed to address critical gaps in analytical capabilities and regulatory readiness for biopharma companies. It will serve as a hub for innovation and collaboration, supporting the development of biologics, biosimilars, and precision medicine.
Shri Duddila Sridhar Babu, Hon'ble Minister for Information Technology, Electronics, Communications, and Industries, Government of Telangana said, 'Hyderabad has emerged as a complete healthcare and life sciences ecosystem—from drug discovery and clinical trials to world-class hospitals and affordable, high-quality patient care. We are proud to host eight of the top ten global pharma companies, five of India's leading healthcare chains, and over 230 USFDA-approved manufacturing facilities. Contributing nearly one-third of India's pharmaceutical production and 40% of bulk drug exports, Telangana is making a strong impact both nationally and globally. With a strong talent base and a clear focus on innovation, we are building a future-ready healthcare system. The launch of the Agilent Biopharma Experience Center is a significant milestone in strengthening Telangana's position as a global leader in life sciences, and a valuable addition to our expanding innovation-driven ecosystem.'
Hyderabad offers one of the most mature and future-focused life sciences ecosystems in India, combining deep industry expertise, strong R&D capabilities, and a supportive policy environment. With its legacy in generics and a growing focus on advanced therapies, the city is well-positioned for the next phase of healthcare innovation. The launch of the Agilent Biopharma Experience Center builds on this foundation, introducing advanced analytical and regulatory capabilities that support both local innovation and global delivery.
This capital investment is part of Agilent's broader three-to-five-year India growth strategy, which includes expanding its footprint, deepening customer partnerships, and positioning India as a strategic hub in Agilent's global innovation and profitability roadmap. The India Solution Center in Manesar, launched earlier this year, further reflects this ongoing commitment—contributing to Agilent's efforts to enhance its presence and capabilities in one of its fastest-growing, high-priority markets globally.
'Agilent is already working closely with many of India's leading biopharma companies,' added McDonnell. 'With this center, we aim to strengthen those relationships and co-create solutions that meet the evolving needs of the Indian and global markets.'
This milestone marks a new chapter in Agilent's journey with India—deepening collaboration, accelerating innovation, and contributing to a healthier, more sustainable future.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
9 minutes ago
- Indian Express
TCS layoffs signal rising strain on Indian IT as AI disruption, US economic woes trigger uncertainty
The recent decision by tech major Tata Consultancy Services (TCS) to lay off 2 per cent of its workforce highlights the growing pressures on India's IT sector, driven by the fast-paced adoption of new technologies like artificial intelligence (AI) and ongoing economic uncertainty in the US, a key market for Indian tech companies. In the first quarter of FY26, a considerable number of IT companies posted weak top-line performance and a squeeze in margins due to the tariff-related uncertainties. Last week, IT bellwether TCS said that it will be laying off 12,000 employees, which is 2 per cent of its global workforce. The move is going to impact employees from the mid and senior levels. Framed as a push toward building a 'future-ready generation' through 'skilling and redeployment,' TCS's move is, in effect, a sweeping cost-cutting exercise. Analysts warn that as the use of AI continues to grow across the IT industry, a significant number of jobs could be at risk. With AI increasingly taking over tasks that were once handled manually — such as coding, data analysis and customer support — companies are likely to reassess workforce needs, potentially leading to widespread layoffs. Experts also point out that roles involving repetitive or process-driven functions are especially vulnerable, unless employees upskill or transition into areas where human oversight and creativity remain essential. 'Aggregate headcount saw a modest quarter-on-quarter increase in Q1 FY26, but several IT companies announced workforce reductions,' BNP Paribas Securities India said in a report. 'TCS laid off nearly 2 per cent of its employees, while HCL Technologies is adjusting its talent deployment outside India, particularly scaling down in the automotive engineering and R&D segment. Wipro incurred a restructuring charge of Rs 247 crore linked to severance payouts in Europe.' Understandably, the employee retrenchment has started the debate of GenAI starting to impact the workforce, it said. The layoffs in the Indian IT sector are increasingly becoming common mainly due to skill mismatches and deployment challenges. 'With growing pressure to reduce costs and align talent with AI-driven models, tech majors are slowing fresher hiring and trimming staff, signalling a structural shift in workforce strategy,' said Arun Kailasan, research analyst – Fundamental Research, Geojit Investments Ltd. Rather than going for lateral hiring, IT firms are focusing on upskilling their existing workforce in emerging areas like AI and generative AI to take care of project execution going ahead. Besides AI, other important factors for layoffs in the IT sector are the macroeconomic headwinds in the US due to tariff-related uncertainty and delay in rate cuts by the US Federal Reserve, resulting in a slower execution of projects by clients. These factors will affect the margins of domestic IT companies. 'During our April 2025 earnings call, we had called out delays in decision-making and projects start with respect to discretionary investments. This trend has continued and intensified to some extent in this quarter,' TCS chief executive officer and managing director, K Krithivasan, said during the Q1 FY26 earnings call. 'Global businesses were disrupted due to conflicts, economic uncertainties and supply chain issues. We saw cost pressures in our customers causing previously unseen project pauses, deferrals and decision delays that resulted in less than expected revenue conversion,' he said. In its recent policy announced on July 30, the Federal Open Market Committee (FOMC) kept the interest rate unchanged at 4.25-4.5 per cent. 'At the beginning of the year, there was an expectation that the US Fed would reduce rates by 50-100 basis points. This cut has been consistently getting extended. When interest rates are high, spending in the US gets impacted, including on IT. This has a bearing on the contracts awarded to Indian IT firms,' said an analyst. Analysts say that due to weak demand, IT companies are likely to slow down their hiring in the near future. 'With muted demand and tighter budgets, companies are focusing on optimising existing talent rather than expanding headcount. Hiring remains subdued, while utilisation rates are rising and attrition has stabilised. The shift is towards value-based deployment and reskilling for AI-driven roles, setting the stage for long-term workforce transformation,' Kailasan of Geojit Investments said. IT analysts said that domestic IT companies are likely to see soft earnings for the rest of 2025 amid volatile and uncertain geopolitical conditions. 'The main challenge remains the slowdown in decision-making among major US clients,' said Ashish Gupta, chief investment officer at Axis Mutual Fund. 'There's a lot of uncertainty around the outlook—questions about retail spending, how consumers will respond to potentially higher interest rates, and whether the US economy can maintain its momentum. The broader economic picture remains unclear.' A report by Nuvama Research said that the demand environment is expected to remain challenging for the next one to two quarters for the IT sector due to the macro — tariff-related — uncertainty. 'In the near term, we expect lack of clarity on macro to continue until most of the trade deals are announced. In general, a large part of the impact of delays was felt in Q1 FY26. The second quarter of FY26 can have some residual impact of the delays. If there are no further delays, Q2 FY26 will be at least better than the first quarter,' said Sumit Pokharna, vice president (Fundamental Research), Kotak Securities. IT sector experts anticipate recovery in 2026 as clarity on the US tariffs emerges and potential rate cuts by the US Federal Reserve help revive demand.
&w=3840&q=100)
First Post
9 minutes ago
- First Post
Tied with China, India is ‘effectively funding Russia's war in Ukraine', says top Trump aide
A top aide to President Donald Trump on Sunday accused India of effectively financing Russia's war in Ukraine by purchasing oil from Moscow, after the U.S. leader escalated pressure on New Delhi to stop buying Russian oil. read more A senior official in the Trump administration on Sunday accused India of effectively funding Russia's war in Ukraine by continuing to purchase oil from Moscow, as President Donald Trump intensified calls for New Delhi to halt its energy imports from Russia. 'What he (Trump) said very clearly is that it is not acceptable for India to continue financing this war by purchasing the oil from Russia,' said Stephen Miller, deputy chief of staff at the White House and one of Trump's most influential aides. STORY CONTINUES BELOW THIS AD Miller's criticism was some of the strongest yet by the Trump administration about one of the United States' major partners in the Indo-Pacific. 'People will be shocked to learn that India is basically tied with China in purchasing Russian oil. That's an astonishing fact,' Miller said on Fox News' 'Sunday Morning Futures.' The Indian Embassy in Washington did not immediately respond to a request for comment. Indian government sources told Reuters on Saturday that New Delhi will keep purchasing oil from Moscow despite US threats. A 25% tariff on Indian products went into effect on Friday as a result of its purchase of military equipment and energy from Russia. Trump has also threatened 100% tariffs on U.S. imports from countries that buy Russian oil unless Moscow reaches a major peace deal with Ukraine. Miller tempered his criticism by noting Trump's relationship with Indian Prime Minister Narendra Modi, which he described as 'tremendous.' With inputs from agencies
Time of India
18 minutes ago
- Time of India
'Surprise': Putin's Men AMBUSH Ukrainian Troops To Capture Donetsk Settlement; Zelensky's Men Flee
India's Crude Oil Imports From U.S. Jump 51% Since Donald Trump's Return To White House India has sharply increased crude oil imports from the US during President Donald Trump's second term, marking a major energy policy shift. In the first half of 2025, US crude imports rose over 50% year-on-year, reaching 0.271 million barrels per day. The April–June quarter saw a 114% surge, with the value rising from $1.73 billion to $3.7 billion. In July, imports rose 23% over June, increasing the US share in India's oil mix from 3% to 8%. LNG imports nearly doubled to $2.46 billion, and LPG imports also grew. Talks are ongoing for a long-term LNG deal. Despite growing energy ties, a setback emerged as Trump announced 25% tariffs on Indian goods, effective August 7, citing trade barriers, imbalances, and India's ties with Russia. He posted strong criticism of India on Truth Social, dismissing its economic relationship with the US and calling for separation from Russia-linked economies.#crudeoil #indiaustrade #trumptariffs #energytrade #indiarussia #lng #lpg #truthtalk #geopolitics #internationalrelations #toi #toibharat 15.9K views | 6 hours ago
